Treatment Strategy for Newly Diagnosed T1 High-grade Bladder Urothelial Carcinoma: New Insights and Updated Recommendations (2018) Klaassen Z, Kamat AM, Kassouf W, Gontero P, Villavicencio H, Bellmunt J, van Rhijn BW, et al. Journal article Prognostic Impact of a 12-gene Progression Score in Non-muscle-invasive Bladder Cancer: A Prospective Multicentre Validation Study (2017) Dyrskjot L, Reinert T, Algaba F, Christensen E, Nieboer D, Hermann GG, Mogensen K, et al. Journal article Prostate-specific Membrane Antigen-radioguided Surgery for Metastatic Lymph Nodes in Prostate Cancer (2015) Maurer T, Weirich G, Schottelius M, Weineisen M, Frisch B, Okur A, Kuebler H, et al. Journal article Survival Prediction of Clear Cell Renal Cell Carcinoma Based on Gene Expression Similarity to the Proximal Tubule of the Nephron (2015) Buettner F, Winter S, Rausch S, Reustle A, Kruck S, Junker K, Stenzl A, et al. Journal article SWITCH: A Randomised, Sequential, Open-label Study to Evaluate the Efficacy and Safety of Sorafenib-sunitinib Versus Sunitinib-sorafenib in the Treatment of Metastatic Renal Cell Cancer (2015) Eichelberg C, Vervenne WL, De Santis M, Von Weikersthal LF, Goebell P, Lerchenmueller C, Zimmermann U, et al. Journal article Temsirolimus in daily use: results of a prospective multicentre noninterventional study of patients with metastatic kidney cancer (2014) Schrader AJ, Seseke S, Keil C, Herrmann E, Goebell P, Weikert S, Steffens S, et al. Journal article Inflammatory biomarkers and bladder cancer prognosis: a systematic review (2014) Masson-Lecomte A, Rava M, Real FX, Hartmann A, Allory Y, Malats N Journal article, Review article Reply to Jérôme Verine, Christophe Leboeuf and Philippe Ratajczak's letter to the editor re: Jimsgene Sanjmyatav, Sven Hauke, Mieczyslaw Gajda, et al. Establishment of a multicolour fluorescence in situ hybridisation-based assay for subtyping of renal cel (2014) Sanjmyatav J, Hartmann A, Moch H, Hauke S, Gajda M, Meyer B, Pryalukhin A, et al. Journal article Combination of CK20 and Ki-67 Immunostaining Analysis Predicts Recurrence, Progression, and Cancer-Specific Survival in pT1 Urothelial Bladder Cancer (2014) Bertz S, Otto W, Denzinger S, Wieland WF, Burger M, Stoehr R, Link S, et al. Journal article